Safety analysis of raltegravir/truvada regimen in HIV/HCV co‐infected patients without switchback af...
Safety analysis of raltegravir/truvada regimen in HIV/HCV co‐infected patients without switchback after HCV treatment
About this item
Full title
Author / Creator
Publisher
Switzerland: International AIDS Society
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: International AIDS Society
Subjects
More information
Scope and Contents
Contents
Introduction
Due to drug‐drug interactions of HIV‐ and HCV‐specific antivirals when initiating an HCV‐therapy, the antiretroviral therapy (ART) often has to be changed. The spectrum of applicable antiretrovirals is small, therefore many patients were switched to raltegravir/truvada (RAL/TVD) in our cohort. Due to the relatively low genetic barri...
Alternative Titles
Full title
Safety analysis of raltegravir/truvada regimen in HIV/HCV co‐infected patients without switchback after HCV treatment
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4224928
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4224928
Other Identifiers
ISSN
1758-2652
E-ISSN
1758-2652
DOI
10.7448/IAS.17.4.19644
